Lv31
230 积分 2025-10-17 加入
Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias
4小时前
已完结
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
12天前
已完结
The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
12天前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
28天前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
28天前
已关闭
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
1个月前
已完结
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
2个月前
已完结
Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies
2个月前
已完结
皖公网安备34019202002308
